Team

Leadership, Insight, Innovation.

Alex Arfaei

Alex Arfaei

Partner

Alex has over 12 years of equity research experience and six years of biopharma operating experience, bringing a unique perspective to evaluating investments.

Emily Carroll

Emily Carroll

Administrative Assistant

Emily's steady support helps our team get the details right.

Karen LeVert

Karen LeVert

Venture Partner

Karen has a long history of developing early stage technologies and launching them into the marketplace.

Lee Babiss, PhD

Lee Babiss, PhD

Scientific Advisory Board

Lee has more than 21 years of experience in developing and leading research and development laboratories.

Matthew Boyer

Matthew Boyer

Chief Financial Officer

Matt is a CPA with over 20 years of experience and oversees the firm’s financial and administrative activities.

Antonio Chow

Antonio Chow

Asia Regional Advisor

Antonio serves as the firm's Regional Advisor in Asia.

Glenda Crumpler

Glenda Crumpler

Executive Assistant

Glenda's broad strong organization skills help keep Pappas Capital running smoothly.

Lisa Dreyer

Lisa Dreyer

Senior Associate, Operations

Lisa brings a depth of experience in finance and operations from her years in the Alternative Investments industry.

Geoffrey Ginsburg, MD, PhD

Geoffrey Ginsburg, MD, PhD

Scientific Advisory Board

Geoff is an internationally recognized expert in genomics and personalized medicine.

Mike Grey

Mike Grey

Venture Partner

Mike’s extensive company management background enables him to bring an operational viewpoint to new deal opportunities and existing portfolio companies.

Franz Humer, PhD

Franz Humer, PhD

Venture Partner and Senior Advisor

Dr. Humer brings a wealth of leadership experience from the pharmaceutical and life science industries.

Russel Kaufman, MD

Russel Kaufman, MD

Executive-in-Residence and Scientific Advisory Board

With long-standing interests in both basic and applied cancer research, Russel has held leadership positions in national academic organizations in internal medicine.

Ernie Mario, PhD

Ernie Mario, PhD

Venture Partner

Ernie has 45 years of experience in the research-based pharmaceutical industry.

Tom Mathers

Tom Mathers

Partner

Tom has more than 26 years of executive management experience in the life sciences and medical device industry.

James McNamara, MD

James McNamara, MD

Scientific Advisory Board

Jim has been a faculty member at Duke University for over 30 years, and is a highly regarded leader in the fields of neurology and neuroscience.

Barry Myers, MD, PhD

Barry Myers, MD, PhD

Executive-in-Residence

Barry has been a member of the Duke University faculty for 28 years. His broad base of expertise enables him to provide a distinctive view on portfolio companies.

Art Pappas

Art Pappas

Managing Partner

Art has over 35 years of operating experience as a pharmaceutical and biotechnology industry executive and venture capital investor in life science companies.

Kyle Rasbach, PhD, PharmD

Kyle Rasbach, PhD, PharmD

Managing Partner

Kyle’s deep scientific experience and extensive background in equity research and public market investing bring an important skill set to Pappas Capital.

David Savello, PhD

David Savello, PhD

Venture Advisor and Scientific Advisory Board

Dave has an extensive career, holding senior level positions at companies such as Glaxo Inc., Glaxo Wellcome Inc., Warner Lambert Corporation and Boehringer Ingelheim Ltd.

Bob White

Bob White

Senior Advisor

Bob has an extensive background in the medical device industry, including the successful sale of TYRX to Medtronic in 2013.

Ford Worthy

Ford Worthy

Partner and Senior Advisor

Ford is a lawyer with an extensive background in finance and accounting, and currently serves as a Senior Advisor to Pappas Capital.

Peter Young

Peter Young

Venture Partner

Peter has more than thirty-five years of experience in the biotech and pharmaceutical industries, and leads the firm's efforts in translational medicine.

Cookie Yu, PhD

Cookie Yu, PhD

Associate

Cookie comes from a multidisciplinary scientific background and is actively involved in evaluating investment opportunities for Pappas Capital.